Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 442

1.

Health aspects of cannabis: revisited.

Hollister LE.

Int J Neuropsychopharmacol. 1998 Jul;1(1):71-80.

PMID:
11281947
2.

An approach to the medical marijuana controversy.

Hollister LE.

Drug Alcohol Depend. 2000 Feb 1;58(1-2):3-7.

PMID:
10669050
3.

Pharmacological stress diathesis syndromes': commentary.

Hollister LE.

J Psychopharmacol. 1999;13(3):293-4; discussion 299. No abstract available.

PMID:
10512089
4.

Calcium channel blockers in psychiatric disorders: a review of the literature.

Hollister LE, Trevino ES.

Can J Psychiatry. 1999 Sep;44(7):658-64. Review.

PMID:
10500866
5.

A survey of hospital practices related to pelvic and rectal examinations of psychiatric inpatients.

Varner RV, Hollister LE.

Psychiatr Serv. 1999 Jun;50(6):825-7.

PMID:
10375154
6.

Where's the bias?

Hollister LE.

Ann Intern Med. 1998 Jan 1;128(1):75. No abstract available.

PMID:
9424996
7.

Structural brain scanning in psychiatric patients: a further look.

Hollister LE, Shah NN.

J Clin Psychiatry. 1996 Jun;57(6):241-4.

PMID:
8666560
8.

Calcium channel blockers in psychiatry.

Hollister LE, Garza-Trevino ES.

Prog Drug Res. 1996;47:279-92. Review. No abstract available.

PMID:
8961770
9.

Electrocardiographic screening in psychiatric patients.

Hollister LE.

J Clin Psychiatry. 1995 Jan;56(1):26-9.

PMID:
7836336
10.

New psychotherapeutic drugs.

Hollister LE.

J Clin Psychopharmacol. 1994 Feb;14(1):50-63. Review.

PMID:
8151004
11.

Clinical uses of benzodiazepines.

Hollister LE, Müller-Oerlinghausen B, Rickels K, Shader RI.

J Clin Psychopharmacol. 1993 Dec;13(6 Suppl 1):1S-169S. Review. No abstract available.

PMID:
7905883
12.

New antidepressants.

Hollister LE, Claghorn JL.

Annu Rev Pharmacol Toxicol. 1993;33:165-77. Review. No abstract available.

PMID:
8494338
13.

Drugs for cocaine dependence: not easy.

Hollister LE, Krajewski K, Rustin T, Gillespie H.

Arch Gen Psychiatry. 1992 Nov;49(11):905-6. No abstract available.

PMID:
1444730
14.

Marijuana and immunity.

Hollister LE.

J Psychoactive Drugs. 1992 Apr-Jun;24(2):159-64. Review.

PMID:
1506999
15.

Neuroleptic dysphoria: so what's new?

Hollister LE.

Biol Psychiatry. 1992 Mar 1;31(5):531-2. No abstract available.

PMID:
1349831
16.

Automobile driving by psychiatric patients.

Hollister LE.

Am J Psychiatry. 1992 Feb;149(2):274. No abstract available.

PMID:
1734755
17.

Verapamil versus lithium in acute mania.

Garza-Treviño ES, Overall JE, Hollister LE.

Am J Psychiatry. 1992 Jan;149(1):121-2.

PMID:
1728160
18.

Stability of psychiatric diagnoses among acutely ill patients.

Hollister LE.

Psychopathology. 1992;25(4):204-8.

PMID:
1492144
19.

Clinical use of CT and MR scans in psychiatric patients.

Hollister LE, Boutros N.

J Psychiatry Neurosci. 1991 Nov;16(4):194-8.

20.

Predicting lithium dose by the body-weight method.

Groves GE, Clothier JL, Hollister LE.

Int Clin Psychopharmacol. 1991 Spring;6(1):19-23.

PMID:
2071886
21.

Treatment outcome: a neglected area of drug abuse research.

Hollister LE.

Drug Alcohol Depend. 1990 Apr;25(2):175-7. No abstract available.

PMID:
2328652
22.

Problems in the search for cognition enhancers.

Hollister LE.

Pharmacopsychiatry. 1990 Feb;23 Suppl 2:33-6. Review.

PMID:
2186410
23.

Avoiding neurotoxicity with lithium-carbamazepine combinations.

McGinness J, Kishimoto A, Hollister LE.

Psychopharmacol Bull. 1990;26(2):181-4.

PMID:
2236454
24.
25.

Interactions between alcohol and benzodiazepines.

Hollister LE.

Recent Dev Alcohol. 1990;8:233-9. Review.

PMID:
1970665
26.

Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation.

Garza-Treviño ES, Hollister LE, Overall JE, Alexander WF.

Am J Psychiatry. 1989 Dec;146(12):1598-601.

PMID:
2686478
27.

Site-specific drug delivery to CNS: old and new.

Hollister LE.

Neurobiol Aging. 1989 Sep-Oct;10(5):631; discussion 648-50.

PMID:
2812240
28.

Peregrinations among drugs of dependence: Nathan B. Eddy Memorial Award lecture.

Hollister LE.

NIDA Res Monogr. 1989;95:36-43. No abstract available.

PMID:
2640995
29.
30.

Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.

Johansson E, Halldin MM, Agurell S, Hollister LE, Gillespie HK.

Eur J Clin Pharmacol. 1989;37(3):273-7.

PMID:
2558889
31.

Psychopharmacology: the bridge between psychiatry and biology.

Hollister LE.

Clin Pharmacol Ther. 1988 Aug;44(2):123-7.

PMID:
3293871
32.

Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms.

Csernansky JG, Riney SJ, Lombrozo L, Overall JE, Hollister LE.

Arch Gen Psychiatry. 1988 Jul;45(7):655-9.

PMID:
3289523
33.

Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users.

Johansson E, Agurell S, Hollister LE, Halldin MM.

J Pharm Pharmacol. 1988 May;40(5):374-5.

PMID:
2899638
34.

The effect of benzodiazepines on tardive dyskinesia symptoms.

Csernansky JG, Tacke U, Rusen D, Hollister LE.

J Clin Psychopharmacol. 1988 Apr;8(2):154-5. No abstract available.

PMID:
3372715
35.

Alprazolam as an antidepressant.

Warner MD, Peabody CA, Whiteford HA, Hollister LE.

J Clin Psychiatry. 1988 Apr;49(4):148-50. Review.

PMID:
3281931
36.

Marijuana and immunity.

Hollister LE.

J Psychoactive Drugs. 1988 Jan-Mar;20(1):3-8. Review.

PMID:
3292743
37.
38.

Cannabis--1988.

Hollister LE.

Acta Psychiatr Scand Suppl. 1988;345:108-18. Review.

PMID:
2852450
39.

Single-dose kinetics of deuterium-labelled cannabinol in man after intravenous administration and smoking.

Johansson E, Ohlsson A, Lindgren JE, Agurell S, Gillespie H, Hollister LE.

Biomed Environ Mass Spectrom. 1987 Sep;14(9):495-9.

PMID:
2960395
40.

An adjunctive role for ascorbic acid in the treatment of schizophrenia?

Beauclair L, Vinogradov S, Riney SJ, Csernansky JG, Hollister LE.

J Clin Psychopharmacol. 1987 Aug;7(4):282-3. No abstract available.

PMID:
3624518
41.

Trazodone and priapism.

Warner MD, Peabody CA, Whiteford HA, Hollister LE.

J Clin Psychiatry. 1987 Jun;48(6):244-5.

PMID:
3584080
42.

Neuroleptics and the elderly.

Peabody CA, Warner MD, Whiteford HA, Hollister LE.

J Am Geriatr Soc. 1987 Mar;35(3):233-8. No abstract available.

PMID:
2880887
43.

A comparison of the neurochemical and behavioral effects of clenbuterol and desipramine.

Finnegan KT, Terwilliger MM, Berger PA, Hollister LE, Csernansky JG.

Eur J Pharmacol. 1987 Feb 10;134(2):131-6.

PMID:
3032650
44.

Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics.

Prosser ES, Csernansky JG, Kaplan J, Thiemann S, Becker TJ, Hollister LE.

J Nerv Ment Dis. 1987 Feb;175(2):100-5.

PMID:
2879880
45.

Strategies in clinical psychopharmacology.

Hollister LE.

Psychopharmacol Bull. 1987;23(3):389-94. Review. No abstract available.

PMID:
3324150
46.

Plasma concentrations of thiothixene and clinical response in treatment-resistant schizophrenics.

Hollister LE, Lombrozo L, Huang CC.

Int Clin Psychopharmacol. 1987 Jan;2(1):77-82.

PMID:
3312399
47.

Alprazolam dependence in mice.

Gallaher EJ, Jacques CJ, Hollister LE.

Alcohol Drug Res. 1987;7(5-6):503-10.

PMID:
2887175
48.

Novel drug treatments for schizophrenia.

Hollister LE.

Psychopharmacol Bull. 1987;23(1):82-4. No abstract available.

PMID:
2885891
49.

Mouse lines selected for genetic differences in diazepam sensitivity.

Gallaher EJ, Hollister LE, Gionet SE, Crabbe JC.

Psychopharmacology (Berl). 1987;93(1):25-30.

PMID:
2819924
50.

Human pharmacology of 1S and 1R enantiomers of delta-3-tetrahydrocannabinol.

Hollister LE, Gillespie HK, Mechoulam R, Srebnik M.

Psychopharmacology (Berl). 1987;92(4):505-7.

PMID:
2819920

Supplemental Content

Loading ...
Support Center